Skip to content

Normothermia Protocol for Traumatic Brain Injury Patients

Normothermia Protocol for Traumatic Brain Injury Patients: An Outcome Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01354509
Enrollment
80
Registered
2011-05-17
Start date
2011-05-31
Completion date
2013-05-31
Last updated
2011-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury

Keywords

Normothermia, fever control, Outcome study

Brief summary

Comparison between a normothermia protocol and current protocol (acetaminophen plus blankets) 1. Normothermia Protocol is successful in achieving and maintaining normal temperature in moderate to severe Traumatic Brain Injury (TBI) patients.(using Arctic Sun for 96 hrs from admission to Neuro ICU) 2. Normothermia is translated into improved neurologic Outcome and survival compared to standard of care (Physician management)

Interventions

None listed

Sponsors

Medivance, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Severe TBI patients(GCS 3-9) admitted to ICU

Exclusion criteria

* Less than 18 years OLD. * Bleeding disorders. * Pregnancy/Breastfeeding. * Hepatic Encephalopathy. * Spinal cord injury (know or new) * Fever \>100 F prior to randomization. * Blood Alcohol level \>80 * Participation in other Research trial. * Inability/unwilling to obtain Informed consent. * Terminal illness(not expected to survive 3-6 months) * Not expected to survive 24 hrs.

Design outcomes

Primary

MeasureTime frameDescription
Neurologic Outcome of the 2 patient populations1month, 3 months, 6 monthsModified Rankin Scale at Hospital discharge, 3 months, and 6 months
Effectiveness of the Normothermia protocol5 daysNumber of times patient's temp was above 37°C during this 96 hr period
Temperature vs ICP5 daysNumber of times ICP \> 20 in patients with ICP monitors

Secondary

MeasureTime frameDescription
Mortality5 days, 3 months, 6 monthsIn-Hospital mortality, 3 - 6 month mortality

Countries

United States

Contacts

Primary ContactFarid Sadaka, MD
farid.sadaka@mercy.net214-251-6486
Backup ContactCatherine Krause, RN
krauca@mercy.net314-251-5653

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026